financetom
AEVA
financetom
/
Consumer Discretionary
/
AEVA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Aeva Technologies, Inc.AEVA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
398.86M
Revenue (ttm)
9.07M
Net Income (ttm)
-152.26M
Shares Out
54.71M
EPS (ttm)
-2.85
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
408,076
Open
7.41
Previous Close
7.51
Day's Range
7.16 - 7.72
52-Week Range
2.20 - 7.74
Beta
1.03
Analysts
Buy
Price Target
6.54 (-10.29%)
Earnings Date
May 6, 2025
Description >

Aeva Technologies, Inc. designs 4D LiDAR-on-chips in the United States, Thailand, Europe, the Middle East, and Asia.

The company develops its products using frequency modulated continuous wave sensing technology. It offers 4D LiDAR sensing system with embedded software for automotive, industrial, and security applications; and a silicon photonics engine and software algorithms for industrial automation and consumer device applications.

The company was founded in 2017 and is based in Mountain View, California.

Latest News >
Bitfarms Completes Sale of Paraguay Data Center to HIVE Digital for US$85 Million
Bitfarms Completes Sale of Paraguay Data Center to HIVE Digital for US$85 Million
Mar 18, 2025
07:35 AM EDT, 03/18/2025 (MT Newswires) -- Bitfarms ( BITF ) said Tuesday that it has completed the sale of its 200 MW data center in Yguazu, Paraguay to HIVE Digital Technologies ( HIVE ) for US$85 million. Bitfarms ( BITF ) had previously said it will reinvest the capital from the sale of the data center sale towards its...
Prime Medicine Launches Preclinical Program for Liver Treatments
Prime Medicine Launches Preclinical Program for Liver Treatments
Mar 18, 2025
07:33 AM EDT, 03/18/2025 (MT Newswires) -- Prime Medicine ( PRME ) said Tuesday it has launched a preclinical program for the treatment of alpha-1 antitrypsin deficiency as part of its liver treatment business. The company said it plans to file an investigational new drug application and/or clinical trial application in mid-2026. Chief Executive Officer and President Keith Gottesdiener said...
Top Premarket Gainers
Top Premarket Gainers
Mar 18, 2025
07:35 AM EDT, 03/18/2025 (MT Newswires) -- Regencell Bioscience ( RGC ) shares surged 72% pre-bell Tuesday, extending Monday's rally. Forafric Global ( AFRI ) shares soared 60% after a 1.2% drop in the previous session. Intellinetics ( INLX ) shares rose 20% after a 2.7% loss on Monday. Harrow (HROW) shares increased 18% after the company reported late Monday...
N2OFF Signs Non-Binding Agreement for Up to 380MW Battery Storage Projects in Italy
N2OFF Signs Non-Binding Agreement for Up to 380MW Battery Storage Projects in Italy
Mar 18, 2025
07:38 AM EDT, 03/18/2025 (MT Newswires) -- N2OFF ( NITO ) said Tuesday that it has signed a non-binding letter of intent with SB Impact 4 and Solterra Brand Services Italy to invest in and develop up to four utility-scale battery energy storage projects in Italy's Puglia region, with a potential total capacity of 380 megawatts. The agreement builds on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved